Fingerprint
Dive into the research topics where Danielle Dixon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Infliximab Concentrations in Participants with Moderate to Severe COVID-19
the ACTIV-1 Study Team, Apr 2024, In: Journal of Clinical Pharmacology. 64, 4, p. 490-491 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
ACTT-4 Study Group, Sep 2022, In: The Lancet Respiratory Medicine. 10, 9, p. 888-899 12 p.Research output: Contribution to journal › Article › peer-review
Open Access100 Link opens in a new tab Scopus citations -
Pandora’s box: Disseminated coccidioidomycosis associated with self-medication with an unregulated potent corticosteroid acquired in Mexico
Jose Coba, A., Sallee, P. K., Dixon, D. O., Alkhateb, R. & Anstead, G. M., Dec 2021, In: Tropical Medicine and Infectious Disease. 6, 4, 207.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations